acein

Acein is a High affinity angiotensin-converting enzyme (ACE) ligand (Kd = 2.79 nM). Exhibits no significant effect on ACE enzymatic activity up to 500 nM concentration. Potentiates NMDA + D-serine-induced dopamine release from striatal slices in vitro and the striatum in vivo.

Acein acetate is a high-affinity angiotensin-converting enzyme (ACE) ligand (Kd = 2.79 nM). Concentrations up to 500 nM had no significant effect on ACE enzyme activity. Enhanced NMDA + D-serine-induced dopamine release from striatal slices in vitro and striatum in vivo.

Fabacein is a useful organic compound for research related to life sciences and the catalog number is T124932.

Jacein is a useful organic compound for research related to life sciences. The catalog number is T124970 and the CAS number is 35305-11-4.

Resinacein L is an inhibitor of α-glucosidase with an IC50 of 0.635 mM. This compound can slow the digestion and absorption of carbohydrates, thereby reducing postprandial blood glucose levels.

Avenacein Y is a biochemical.

Violacein is a bacterial metabolite originally isolated from C. violaceum that has antibacterial and antiprotozoal activities.[1] [2] It is produced by C. violaceum as a purple pigment in response to N-hexanoyl homoserine lactone , a property that has been modified to create a strain of C. violaceum used in detecting quorum-sensing molecules.[3] Violacein is active against Gram-positive bacteria, including B. subtilis and S. aureus (MICs = 0.8 and 1.6 µM, respectively). It is also active against P. falciparum, including chloroquine-susceptible and -resistant strains (IC50s = 0.85 and 0.63 µM, respectively).[2] It reduces parasitemia in a mouse model of nonlethal P. chabaudi chabaudi infection when administered at a dose of 7.5 mg/kg and increases survival in a mouse model of lethal P. chabaudi chabaudi infection. Violacein permeabilizes the cytoplasmic membrane of bacterial cells but does not affect the cell wall.[1]

Deoxyviolacein is a bacterial metabolite and byproduct in the biosynthesis of the bisindole alkaloid violacein, exhibiting anticancer, antibacterial, and antifungal properties. It inhibits hepatocellular carcinoma cell proliferation at concentrations of 0.1 to 1 μM. Deoxyviolacein (125 μg/ml) demonstrates antibacterial activity against Gram-positive bacteria, including S. aureus, B. subtilis, and B. megaterium, and showcases antifungal activity against R. solani at 2 mg/ml.

Oleacein is a natural polyphenol from extra virgin olive oil, exhibiting potent antioxidant and anti-inflammatory properties used in metabolic disease research.

Resinacein D is a natural product that can be used as a reference standard. The CAS number of Resinacein D is 2231061-47-3.

Resinacein C is a natural product that can be used in related research in the field of life sciences. Its product number is TN8528.

Perindoprilat (Perindoprilate) is an angiotensin-converting enzyme inhibitor.

Enalapril is a dicarbocyl-containing peptide and angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity.

K-13 is used as an ACE inhibitor produced by Micromonospora halophytics subsp. exilisia K-13.

BACE-IN-1 is amyloid precursor protein beta-secretase inhibitor

BACE-IN-1 acetate (BACE-IN-1 acetate (350228-37-4,Free base)) has been used as β-site amyloid precursor protein (APP) cleaving enzyme-1 (BACE1) inhibitor in BACE1 inhibitor assay. β-Site amyloid precursor protein (APP) cleaving enzyme-1 (BACE1), an aspartic protease belongs to the protease family of enzymes comprises of six luminal cysteine residues. These residues help in the formation of three intermolecular disulfide bonds and N-linked glycosylation sites.

BACE-IN-1 is an imidazo[1,2-a]pyridine derivative that inhibits the β-site amyloid precursor protein cleavage enzyme (BACE) sentence.BACE-IN-1 has the potential to investigate diseases involving BACE, such as Alzheimer's disease.

Ramiprilat is an angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity.